Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors-Reference-Cited by-同舟云学术

Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors

Published:2023-09-22 Issue:39 Volume:8 Page:36435-36448
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Lee Jong Won¹²,Choi Jiwoong²,Kim Eun Hye²³,Choi Jiwon²⁴,Kim Sun Hwa¹²^ORCID,Yang Yoosoo²^ORCID

Affiliation:

1. KU-KIST Graduate School of Converging Science and Technology, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea

2. Medicinal Materials Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), 5, Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea

3. Department of Life Sciences, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea

4. Department of Bioengineering, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea

Funder

National Research Foundation of Korea

Korea Institute of Science and Technology

Korea University

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c05395

Reference68 articles.

1. Tumor microenvironment complexity and therapeutic implications at a glance

2. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment

3. EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells

4. Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

5. MYC regulates the antitumor immune response through CD47 and PD-L1

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective Chapter: Mastering RNA Interference (RNAi) Delivery – Strategies for Effective Targeting and Gene Silencing;Beyond the Blueprint - Decoding the Elegance of Gene Expression [Working Title];2024-07-12

2. LDLR-Mediated Targeting and Productive Uptake of siRNA-Peptide Ligand Conjugates In Vitro and In Vivo;Pharmaceutics;2024-04-17